Acutus Medical Inc.
| NASDAQ: AFIB | Healthcare / Medical Devices & Instruments / USA |
| 16.30 | -0.3100 | -1.87% | Vol 78.34K | 1Y Perf -38.25% |
| Jun 14th, 2021 16:00 DELAYED |
| BID | 16.30 | ASK | 16.37 | ||
| Open | 16.55 | Previous Close | 16.61 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 22.60 | Analyst Rating | — — 0.00 | |
| Potential % | 38.65 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★★ 57.46 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Market Cap | 458.42M | Earnings Rating | — | |
| Price Range Ratio 52W % | 18.41 | Earnings Date | 12th May 2021 |
Today's Price Range 16.1616.86 | 52W Range 11.1838.99 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -6.27% | ||
| 1 Month | 19.41% | ||
| 3 Months | -9.44% | ||
| 6 Months | -45.83% | ||
| 1 Year | -38.25% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | 159.29 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -90.80 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -45.37 | |||
Return on invested Capital Q | -18.01 | |||
Return on invested Capital Y | -15.51 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 5.60 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -32.50 | ||||
| 4.66 | ||||
| 43.78 | ||||
| - | ||||
| -4.40 | ||||
| -3.34 | ||||
| 5.65 | ||||
| 3.57 | ||||
| 412.79M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 5.30 | ||||
| 6.30 | ||||
| 0.29 | ||||
| 0.41 | ||||
| -19.40 | ||||
| Leverage Ratio | 5.50 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -87.60 | ||||
| -1 026.60 | ||||
| -980.90 | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 10.47M | ||||
| 0.37 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2021 | -0.80 | -1.08 | -35.00 |
| Q04 2020 | -0.81 | -0.99 | -22.22 |
| Q03 2020 | -1.38 | -1.18 | 14.49 |
| Q02 2020 | - | -32.24 | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | -0.70 |
| Estimates Count | 3 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 78.34K |
| Shares Outstanding | 28.12M |
| Trades Count | 1.26K |
| Dollar Volume | 6.20M |
| Avg. Volume | 322.80K |
| Avg. Weekly Volume | 139.59K |
| Avg. Monthly Volume | 258.16K |
| Avg. Quarterly Volume | 312.40K |
Acutus Medical Inc. (NASDAQ: AFIB) stock closed at 16.3 per share at the end of the most recent trading day (a -1.87% change compared to the prior day closing price) with a volume of 78.35K shares and market capitalization of 458.42M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 291 people. Acutus Medical Inc. CEO is Vincent J. Burgess.
The one-year performance of Acutus Medical Inc. stock is -38.25%, while year-to-date (YTD) performance is -43.42%. AFIB stock has a five-year performance of %. Its 52-week range is between 11.18 and 38.99, which gives AFIB stock a 52-week price range ratio of 18.41%
Acutus Medical Inc. currently has a PE ratio of -32.50, a price-to-book (PB) ratio of 4.66, a price-to-sale (PS) ratio of 43.78, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -90.80%, a ROC of -45.37% and a ROE of 159.29%. The company’s profit margin is -%, its EBITDA margin is -980.90%, and its revenue ttm is $10.47 Million , which makes it $0.37 revenue per share.
Of the last four earnings reports from Acutus Medical Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.70 for the next earnings report. Acutus Medical Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Acutus Medical Inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Acutus Medical Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Acutus Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Acutus Medical Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 55.12, ATR14 : 1.08, CCI20 : 57.00, Chaikin Money Flow : 0.03, MACD : 0.83, Money Flow Index : 53.53, ROC : 14.07, RSI : 58.12, STOCH (14,3) : 57.50, STOCH RSI : 0.00, UO : 45.84, Williams %R : -42.50), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Acutus Medical Inc. in the last 12-months were:
Acutus Medical Inc.
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.
CEO: Vincent J. Burgess
Telephone: +1 442 232-6080
Address: 2210 Faraday Avenue, Carlsbad 92008, CA, US
Number of employees: 291
